Abstract: The present invention relates to a pharmaceutical composition for the treatment of castration-resistant prostate cancer, comprising bruceantin and nanoparticles. Using the composition comprising bruceantin and nanoparticles according to an embodiment, it is possible to effectively treat castration-resistant prostate cancer by reducing the side effects of bruceantin and overcoming the poor solubility thereof.

Abstract: The present invention provides a system for autonomously conveying and loading a shell into a fixed gun, the system including an autonomous conveyance device configured to autonomously travel and move according to an autonomous driving program from a shell storage location to a fixed gun fixed to a gun mount that is a destination, an automatic loading device configured to hold a testing shell and automatically load the testing shell into a cartridge chamber of the fixed gun, and a shell lifting device mounted on an upper surface of the autonomous conveyance device and a lower surface of the automatic loading device and configured to move the automatic loading device upward or downward. According to the present invention, a process of conveying and loading the shell into the testing fixed gun may be autonomously performed in an unmanned manner.

Abstract: Example embodiments include a battery insulation sheet having a structure in which a first substrate, an aerogel layer, and a second substrate are laminated, wherein opposite surfaces of the aerogel layer is in contact with the first substrate or the second substrate adjacent thereto. Example embodiments also include a method of manufacturing a battery insulation sheet, and a battery module including the battery insulation sheet.

Abstract: An apparatus for controlling an electro-mechanical braking system includes a first braking control module configured to receive at least one of an electronic parking brake (EPB) switch signal, a braking control signal, or a cylinder pressure value and to operate a parking brake and an additional braking valve; a second braking control module configured to receive at least one of a brake pedal signal, the braking control signal, or the cylinder pressure value and to operate a braking motor and a main braking valve, a first power module configured to supply power to the first braking control module, a second power module configured to supply power to the second braking control module, an integrated switch configured to integrate output powers of the first power module and the second power module, and a connection bus configured to transfer transmission and reception signals, and a method thereof.

Abstract: An apparatus for controlling viscosity of a slurry includes a mixing module mixing raw materials for a secondary battery, and a processor performing machine learning for prediction of viscosity of the slurry, predicting viscosity of the slurry in real time during a mixing process through machine learning, and adjusting conditions of the mixing process performed by the mixing module such that a predictive viscosity of the slurry meets a target viscosity.

Abstract: The present invention provides a sounding device including a housing body having a containment cavity and a sounding unit placed in the containment cavity. The sounding unit includes a vibration system and a magnetic circuit system. The sounding device includes a box, a coil, a circuit board, and an elastic assembly. The elastic assembly is used to suspend the box in the containment cavity. The present invention coil shares a magnetic circuit system with the vibration system and the sounding unit is directly used as the weight unit of the coil. The parts are shared to the greatest extent, the assembly process is simplified, and the cost is reduced.

Abstract: A multifunctional biobased waterborne polyurethane composition includes, based on 100 parts by weight of the polyurethane composition, 40 to 50 parts by weight of a polyol, 34 to 42 parts by weight of an isocyanate, 8 to 14 parts by weight of a chain extender, 0.03 to 0.12 parts by weight of a catalyst, and 0.005 to 0.02 parts by weight of a neutralizing agent.

Abstract: An electric bayberry picker with direct cooling and fast encapsulation based on machine vision includes: a mechanical claw with at least three flexible fingers, wherein each flexible finger is equipped with a pressure sensor on one side facing the bayberry, and a collecting pipe is arranged at an enclosing center of all the flexible fingers; an image recognition device configured for positioning and recognizing maturity of the bayberry; a carbon dioxide spraying device for spraying carbon dioxide on a fruit stalk and around the bayberry to freeze the fruit stalk and reduce the surface temperature of the bayberry; a photoelectric sensor for detecting whether a bayberry exits an outlet of the collecting pipe; a liquid polyurethane foam spraying device for wrapping the bayberry exited the outlet of the collecting pipe with the liquid polyurethane foam; and a transportation device.

Abstract: An electric bayberry picker with direct cooling and fast encapsulation based on machine vision includes: a mechanical claw with at least three flexible fingers, wherein each flexible finger is equipped with a pressure sensor on one side facing the bayberry, and a collecting pipe is arranged at an enclosing center of all the flexible fingers; an image recognition device configured for positioning and recognizing maturity of the bayberry; a carbon dioxide spraying device for spraying carbon dioxide on a fruit stalk and around the bayberry to freeze the fruit stalk and reduce the surface temperature of the bayberry; a photoelectric sensor for detecting whether a bayberry exits an outlet of the collecting pipe; a liquid polyurethane foam spraying device for wrapping the bayberry exited the outlet of the collecting pipe with the liquid polyurethane foam; and a transportation device.

Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof. The formulations may further contain a formulation buffer, a viscosity reducer, and a non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit low viscosity and a substantial degree of antibody stability after being subjected to thermal and other physical stress. Also provided are methods of making and methods of using such antibody formulations.

Abstract: An aerogel composition for battery insulation sheets includes a reinforcement material including two or more fibrous supports, an aerogel, a functional material including a binder, a dispersant, or a combination thereof, and a solvent, wherein the two or more fibrous supports have different aspect ratios (AR) as represented by Formula 1: AR=L/D,??Formula 1 where in Formula 1, L indicates an average length of a fibrous support of the two or more fibrous supports and D indicates an average diameter of the two or more fibrous supports.

Abstract: Example embodiments include an aerogel composition for battery insulation sheets, the aerogel composition including a reinforcement material including a first fibrous support and a second fibrous support, an aerogel, a functional material including a binder, a dispersant, or a combination thereof, and a solvent, wherein the first fibrous support and the second fibrous support have different ingredients. Example embodiments also include a method of manufacturing the aerogel composition, a battery insulation sheet formed using the aerogel composition, and a method of manufacturing the battery insulation sheet.

Abstract: Disclosed is an electronic device for implementing a temperature prediction and control system.

Abstract: Examples of the disclosure include a battery module including a plurality of cells, an insulation sheet between the plurality of cells, the insulation sheet having an upper surface and a lower surface disposed so as to face cells adjacent thereto, respectively, and a refractory layer formed on at least one side surface part of a border side surface between the upper surface and the lower surface of the insulation sheet, wherein the refractory layer includes an inorganic binder. Examples of the disclosure also include a method of manufacturing the battery module, and a battery pack including the battery module.

Abstract: One example blood pressure measurement device includes a body, a wrist strap, an airbag, an air supply and exhaust apparatus, a first sensor, and a second sensor. The airbag has an air cavity, and the airbag is connected to the body. The body includes a cavity, and the air supply and exhaust apparatus is disposed in the cavity. The air supply and exhaust apparatus includes an air intake path and an air exhaust path, and the air supply and exhaust apparatus communicates with the air cavity of the air bag. The first sensor is configured to measure an air pressure value in the air cavity. The second sensor is located on a same side of the wrist strap as the airbag, and is configured to measure a pulse wave signal.

Abstract: A motor driving redundancy device for an electronic parking brake includes a first motor-driving module configured to supply current to a motor, a first driver module configured to control the first motor-driving module, a second motor-driving module configured to drive the motor, a second driver module configured to control the second motor-driving module, a monitoring module configured to monitor a status of the first motor-driving module and the second motor-driving module, and a processor configured to, when a failure is detected in either the first motor-driving module or the second motor-driving module by the monitoring module, control at least one of the first motor-driving module or the second motor-driving module to drive the motor.

Abstract: The invention discloses a fusion protein and its preparation method for intermediate polypeptide of Semaglutide. The invention belongs to the technical field of genetic engineering and polypeptide preparation. The fusion protein comprises a fusion peptide, a protease cleavage site and a target main molecular sequence. By optimizing the fusion peptide sequence, changing the isoelectric point and hydrophilicity of the protein, the highest expression of the fusion protein is effectively increased to 13.1 g/L. Meanwhile, the properties of fusion protein are also improved, which is conducive to the development of subsequent extraction, enzyme digestion and purification processes. The yield of intermediate polypeptide after enzyme digestion is 3.62 g/L. The production cost of Semaglutide intermediate polypeptide Arg34GLP-1(9-37) is reduced from the source, which is conducive to industrial scale-up and suitable for industrial production.

Abstract: Methods and systems are described for conversion of an optical signal. The device may comprise a conversion layer comprising a nonlinear optical material with a surface structure disposed to receive a pump signal and cause a bound states in the continuum (BIC) optical mode. The conversion layer may be configured to convert, based on nonlinear interaction with the BIC optical mode, an incoming signal incident on the conversion layer from an incoming wavelength to a target wavelength.

Abstract: A method to control the cooldown of main heat exchangers in liquefied natural gas plant. The method provides for the automated control of a flow rate of a natural gas feed stream through a heat exchanger based on one or more process variables and set points. The flow rate of refrigerant streams through the heat exchanger is controlled by different process variables and set points, and is controlled independently of the flow rate of the natural gas feed stream.

Abstract: The invention discloses a fusion protein and its preparation method for intermediate polypeptide of Semaglutide. The invention belongs to the technical field of genetic engineering and polypeptide preparation. The fusion protein comprises a fusion peptide, a protease cleavage site and a target main molecular sequence. By optimizing the fusion peptide sequence, changing the isoelectric point and hydrophilicity of the protein, the highest expression of the fusion protein is effectively increased to 13.1 g/L. Meanwhile, the properties of fusion protein are also improved, which is conducive to the development of subsequent extraction, enzyme digestion and purification processes. The yield of intermediate polypeptide after enzyme digestion is 3.62 g/L. The production cost of Semaglutide intermediate polypeptide Arg34GLP-1(9-37) is reduced from the source, which is conducive to industrial scale-up and suitable for industrial production.